If the cells you would like to access are currently listed as unavailable
or you are ordering from outside of Europe please get in touch via
Contact@EBiSC.org.
WTSIi073-A
HPSI0314i-sojd_3
iPSC line
The cell line was withdrawn.
General#
Cell Line |
|
hPSCreg name | WTSIi073-A |
Alternative name(s) |
HPSI0314i-sojd_3
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Provider |
|
Depositor | Wellcome Sanger Institute (WTSI) |
Distributors |
|
Derivation country | United Kingdom |
External Databases |
|
hPSCreg | WTSIi073-A |
BioSamples | SAMEA2627569 |
HipSci | HPSI0314i-sojd_3 |
Cellosaurus | CVCL_AE87 |
Wikidata | Q54890627 |
General Information |
|
Publications | View all related publications on hPSCreg (2) |
This EBiSC line can be used for: |
Yes
Research use: allowed
Clinical use: no
Commercial use: no
|
Donor Information#
General Donor Information |
|
Sex | female |
Age of donor (at collection) | 45-49 |
Ethnicity | White - Other |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Donor Relations |
|
Other cell lines of this donor | |
External Databases (Donor) |
|
BioSamples | SAMEA2418245 |
HipSci | HPSI-sojd |
hIPSC Derivation#
General |
|
Source cell type |
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
|
Source cell origin |
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Synonyms
|
Age of donor (at collection) | 45-49 |
Collected in | 2014 |
Source cell line vendor | Cambridge BioResource |
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Genes | |
Notes on reprogramming vector detection | CytoTune 1 |
Vector free reprogramming |
|
Other |
|
Selection criteria for clones | Morphology |
Derived under xeno-free conditions |
No |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions#
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating | Vitronectin |
Feeder cells |
No |
Passage method |
Enzyme-free cell dissociation
EDTA
|
CO2 Concentration | 5 % |
Medium |
TeSR™ E8™
|
Characterisation#
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|
||||
SOX2 |
Yes |
|
||||
NANOG |
Yes |
|
Pluripotency Score | Novelty Score | Link to microarray data |
24.625 | 1.479 | http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4057/ |
Report
HPSI-sojd.pluritest.pluripotency_score.20161010.png
pluripotency image
HPSI-sojd.pluritest.novelty_score.20161010.png
novelty image
Genotyping#
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
Is there genome-wide genotyping or functional data available? |
Yes
Exome sequencing
http://www.ebi.ac.uk/ena/data/view/ERZ266817
cnv
http://www.hipsci.org/lines/#/lines/HPSI0314i-sojd_3 Number of regions different from primary tissue: 0; Length of differences from primary tissue: 0 |
WGS-derived disease associations |
Charcot-Marie-Tooth disease (FIG4, HINT1)
Cohen syndrome (VPS13B)
complex neurodevelopmental disorder (SETBP1)
demyelinating hereditary motor and sensory neuropathy (MTMR2)
factor XIII, b subunit, deficiency of (F13B)
Lynch syndrome (PMS1)
mitochondrial disease (NDUFS6)
myopathy caused by variation in POMT1 (POMT1)
nephronophthisis 4 (NPHP4)
nonsyndromic genetic hearing loss (CDH23, MYO7A)
PHARC syndrome (ABHD12)
primary ciliary dyskinesia 2 (DNAAF3)
primary ciliary dyskinesia 7 (DNAH11)
PTEN hamartoma tumor syndrome (PTEN)
Rothmund-Thomson syndrome (RECQL4)
Schinzel-Giedion syndrome (SETBP1)
Smith-Magenis syndrome (RAI1)
syndromic intellectual disability (KMT2C)
turnpenny-fry syndrome (PCGF2)
Usher syndrome type 1 (CDH23, MYO7A)
vitamin K-dependent clotting factors, combined deficiency of, type 2 (VKORC1)
|
Other WGS-derived genes | A2M, AGAP1, AGAP6, AGL, AHNAK, AKR1E2, ALDH3A2, ANAPC1, AURKC, CASP12, CATSPER2, COLQ, CSH2, CYP21A2, D2HGDH, DEFB126, DNAAF1, DSC3, ERCC6L2, FLG2, FUT2, FZD6, GDPD4, GLYCTK, H6PD, IL12RB1, IRF5, ITGB2, KCNJ16, KISS1, KRT18, LAMA5, LDHB, MAPT, MICA, MROH8, NAGLU, NDUFB9, NFU1, NPRL3, NRP2, OAS1, OR1B1, OR51F1, OR52B4, P2RX5, PDE4DIP, PIGN, POLDIP2, POLR3B, PYGL, RXFP2, SELPLG, SIGLEC12, SLC37A4, SRA1, SYNE2, TAP2, TAS2R7, TGIF1, TLR5, TMEM107, TMEM175, TMEM216, TMPRSS6, TNRC18, TOR1AIP1, TREH, TRPM1, VDR, WDR37, ZNF141, ZNF527, ZNF83, ZNF844 |